middle.news
Amplia Therapeutics Advances Pancreatic Cancer Trial, Secures $13M Funding Boost
10:21am on Thursday 30th of January, 2025 AEDT
•
Pharmaceuticals
Read Story
Amplia Therapeutics Advances Pancreatic Cancer Trial, Secures $13M Funding Boost
10:21am on Thursday 30th of January, 2025 AEDT
Key Points
Nine confirmed partial responses in Phase 2a ACCENT trial
Recruitment underway for second cohort of 24 patients, with 12 enrolled
$13 million capital raise completed to fund ongoing trials
Collaboration initiated with Korean biotech Next&Bio for drug screening
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Amplia Therapeutics (ASX:ATX)
OPEN ARTICLE